Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Hyperimmune Globulins Market?

The market size of hyperimmune globulins has significantly expanded in the past few years. It is anticipated to increase from $1.91 billion in 2024 to $2.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.5%. The robust growth witnessed in the historical period is due to augmented government backing and a surge in healthcare spending.

The market for hyperimmune globulins is predicted to experience significant expansion in the upcoming years, with its value projected to reach $2.71 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.1%. Such growth during the projected period could be attributed to the escalating incidences of infectious diseases, heightened awareness relative to the benefits of hyperimmune globulin injections, ascending demand for immunoglobulins, growing occurrences of alpha-1 antitrypsin deficiency, and upward trends of immune deficiencies. The forecast period also suggests noticeable trends such as technological enhancements and innovations, increased investments in research and development, demand for passive immunity treatment methods, advancements made in plasma-derived therapies, and technological progression in manufacturing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp

What Core Drivers Are Expected To Influence The Hyperimmune Globulins Market?

The rise in infectious diseases is predicted to fuel the expansion of the hyperimmune globulin market in the future. It’s important to note that harmful agents like bacteria, viruses, fungi and parasites cause infectious diseases. The escalation in frequency of these diseases can be linked to various factors, including antimicrobial resistance, climate change, and population growth. In the face of infectious diseases, hyperimmune globulins are employed to provide immediate passive immunity by delivering concentrated antibodies against specific pathogens, thereby helping in preventing or treating ailments such as rabies, hepatitis B or tetanus. To exemplify, the Centers for Disease Control and Prevention, a government agency based in the US, reported in April 2024, that chronic hepatitis B cases in the US rose by roughly 17% from 14,229 cases in 2021 to 16,729 cases in 2022. Hence, the rise in infectious diseases is a driving factor for the growth of the hyperimmune globulin market.

What Are The Main Segment Classifications In The Hyperimmune Globulins Market?

The hyperimmune globulinsmarket covered in this report is segmented –

1) By Type: Hepatitis B Hyperimmune Globulin; Rabies Hyperimmune Globulin; Tetanus Hyperimmune Globulin; Cytomegalovirus (CMV) Hyperimmune Globulin; Varicella-Zoster Virus (VZV) Hyperimmune Globulin; Respiratory Syncytial Virus (RSV) Hyperimmune Globulin; Other Types

2) By Route Of Administration: Intramuscular; Intravenous

3) By Application: Government Institution; Private Sector; Other Applications

Subsegments:

1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin; Intravenous Hepatitis B Hyperimmune Globulin

2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human); Rabies Immune Globulin (Equine)

3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human); Tetanus Immune Globulin (Equine)

4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation; Cmv Immune Globulin For Neonatal Infection

5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis; Vzv Immune Globulin For Immunocompromised Patients

6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children; Rsv Immune Globulin For Adults With Respiratory Conditions

7) By Other Types: Diphtheria Hyperimmune Globulin; Botulism Hyperimmune Globulin; Other Specialized Hyperimmune Globulins

Which Companies Are Contributing Significantly To The Hyperimmune Globulins Market Growth?

Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Which Region Holds The Greatest Opportunity For Hyperimmune Globulins Market Expansion?

North America was the largest region in the hyperimmune globulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16448&type=smp

Browse Through More Reports Similar to the Global Hyperimmune Globulins Market 2025, By The Business Research Company

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Hypersonic Missiles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hypersonic-missiles-global-market-report

Hyperspectral Imaging System Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hyperspectral-imaging-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model